Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

drugs

The Oxford Colloquy

The Pandemic People: Sir Pascal Soriot

Sir Andrew Pollard talks to Sir Pascal Soriot, the CEO of AstraZeneca about their pandemic partnership to develop the AstraZeneca/Oxford vaccine. Over three billion vaccines have been delivered, saving six and a half million lives.
Anthropology

A War on People: The Drug War and the Hermeneutic Politics of Those who Resist it

This Anthropology Departmental Seminar was given by Jarrett Zigon (University of Virginia) on 2 December 2016.
Journey of a Molecular Detective; David Sherratt

Drug and Target Discovery in Parkinson's Disease

Prof. Richard Wade-Martins discusses how you pick promising new drugs targets for Parkinson's
Department of Social Policy and Intervention

Research, Policy, and Societal Perspectives on New Psychoactive Substances

Part four of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014.
Department of Social Policy and Intervention

Adolescent Substance Use: What Do We Think We Know, Should We Intervene and if so, When?

Part two of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014.
Department of Social Policy and Intervention

Drug Control, Human Rights and Bridging 'Parallel Universes'

Part one of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014.
Oxford Martin School: Public Lectures and Seminars

Why do we need to reconstruct drug discovery?

Dr Javier Lezaun and Professor Chas Bountra give a talk about drug discovery.
Revolutionary Biology

Part 4: A New Age of Drug Discovery

You just have to step into your local chemist to see how far medicine has come over the past 100 years. Life changing drugs, which were once unthinkable – like antibiotics, insulin and the contraceptive pill – are now commonplace.
Alumni Weekend

Why is Oxford Determined to Change the Way We Discover New Medicines?

Chas Bountra, a popular speaker at the recent Meeting Minds: Alumni Weekend in Asia, will explain how Oxford is creating a new ecosystem for drug discovery.
Journey of a Molecular Detective; David Sherratt

Deadly Devices and Dangerous Drugs, the Secrets Behind Medical Research

A talk hosted by Kellogg College and the Centre for Evidence-Based Medicine at the University Museum of Natural History, as part of the University's Alumni Weekend.
Alumni Weekend

Big Data and Drug Discovery (The Osler Discussion)

'Big data' in medicine is an emerging field with the potential to revolutionise healthcare research.This session will look at how Oxford is addressing some of these research opportunities and challenges.
Chemistry for the Future: Human Health

3D Printing and The Structure of Proteins

Using 3D printed molecules, Rok Sekirnik, a DPhil student in the emerging field of chemical biology, shows how protein structures can be determined in some of the Department's most distinctive looking labs.
Journey of a Molecular Detective; David Sherratt

OxPeace 2013: Illicitily Governed Spaces: drugs, conflict and peace in Columbia Session 1A: Counter-Terrorism and Peacebuilding

Annette Idler, gives a talk for the OxPeace 2013 conference: The Future of Peace Building.
Somerville College

How can we get the media to tell the truth about drugs?

Professor David Nutt (Imperial College London) delivers the 2011 Monica Fooks Memorial Lecture.
Bio-Ethics Bites

Bio-Ethics Bites

Demand for health care is infinite, but money is finite. So how should we distribute resources? Whom should we help, and why?
Entrepreneurship

Oxford at Said Seminar: Drug Discovery

In this seminar two academics explore experimental medicine in early-phase clinical trials and reforming intellectual property.
Medical Innovation

Medical Innovation 2010: Parallel Session 8

Financing Innovation: How can we utilise novel mechanisms to fund innovation?
Medical Innovation

Medical Innovation 2010: Parallel Session 7

Evaluating Innovation: How do we evaluate innovation appropriately?
Medical Innovation

Medical Innovation 2010: Parallel Session 6

Clinical Entrepreneurship.
Medical Innovation

Medical Innovation 2010: Parallel Session 5

Entrepreneurship in the Community.

Pagination

  • Current page 1
  • Page 2
  • Next page
  • Last page

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford